|
1
|
Maeda SS and Lazaretti-Castro M: An
overview on the treatment of postmenopausal osteoporosis. Arq Bras
Endocrinol Metabol. 58:162–171. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Janiszewska M, Kulik TB, Dziedzic MA and
Żołnierczuk-Kieliszek D: The contemporary look at the problem of
recognizing and diagnosing postmenopausal osteoporosis and
eliminating the risk of a fall. Prz Menopauzalny. 13:42–47.
2014.PubMed/NCBI
|
|
3
|
Jaha H, Husein D, Ohyama Y, Xu D, Suzuki
S, Huang GT and Mochida Y: N-terminal Dentin Sialoprotein fragment
induces type I collagen production and upregulates dentinogenesis
marker expression in osteoblasts. Biochem Biophys Rep. 6:190–196.
2016.PubMed/NCBI
|
|
4
|
Rydziel S, Varghese S and Canalis E:
Transforming growth factor beta1 inhibits collagenase 3 expression
by transcriptional and post-transcriptional mechanisms in
osteoblast cultures. J Cell Physiol. 70:145–152. 1997. View Article : Google Scholar
|
|
5
|
Katz LH, Li Y, Chen JS, Muñoz NM, Majumdar
A, Chen J and Mishra L: Targeting TGF-beta signaling in cancer.
Expert Opin Ther Targets. 17:743–760. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
López-Casillas F, Wrana JL and Massagué J:
Betaglycan presents ligand to the TGF beta signaling receptor.
Cell. 73:1435–1444. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wrana JL, Attisano L, Wieser R, Ventura F
and Massagué J: Mechanism of activation of the TGF-beta receptor.
Nature. 370:341–347. 1994. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Heldin CH, Miyazono K and ten Dijke P:
TGF-beta signalling from cell membrane to nucleus through SMAD
proteins. Nature. 390:465–471. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Derynck R, Zhang Y and Feng XH: Smads:
Transcriptional activators of TGF-beta responses. Cell. 95:737–740.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu M, Chen G and Li YP: TGF-β and BMP
signaling in osteoblast, skeletal development, and bone formation,
homeostasis and disease. Bone Res. 4:160092016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Steiner RD, Adsit J and Basel D:
COL1A1/2-related osteogenesis imperfectaGeneReviews. Pagon RA, Adam
MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD,
Ledbetter N, Mefford HC, Smith RJH and Stephens K: University of
Washington; Seattle, WA: 2005
|
|
12
|
Saito M and Marumo K: Collagen cross-links
as a determinant of bone quality: A possible explanation for bone
fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos
Int. 21:195–214. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gelse K, Pöschl E and Avinger T:
Collagens-structure, function, and biosynthesis. Adv Drug Deliv
Rev. 55:1531–1546. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen G, Deng C and Li YP: TGF-β and BMP
signaling in osteoblast differentiation and bone formation. Int J
Biol Sci. 8:272–288. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mukasa C, Nomura M, Tanaka T, Tanaka K,
Nishi Y, Okabe T, Goto K, Yanase T and Nawata H: Activin signaling
through type IB activin receptor stimulates aromatase activity in
the ovarian granulosa cell-like human granulose (KGN) cells.
Endocrinology. 144:1603–1611. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Arjmandi BH: The role of phytoestrogens in
the prevention and treatment of osteoporosis in ovarian hormone
deficiency. J Am Coll Nutr. 20 5 Suppl:398S–402S, 417S-420S. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Komm BS, Terpening CM, Benz DJ, Graeme KA,
Gallegos A, Korc M, Greene GL, O'Malley BW and Haussler MR:
Estrogen binding, receptor mRNA, and biologic response in
osteoblast-like osteosarcoma cells. Science. 241:81–84. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Majeska RJ, Ryaby JT and Einhorn TA:
Direct modulation of osteoblastic activity with estrogen. J Bone
Joint Surg Am. 76:713–721. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Benz DJ, Haussler MR and Komm BS: Estrogen
binding and estrogenic responses in normal human osteoblast-like
cells. J Bone Miner Res. 6:531–541. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Virk-Baker MK, Nagy TR and Barnes S: Role
of phytoestrogens in cancer therapy. Planta Med. 76:1132–1142.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yamaguchi M and Sugimoto E: Stimulatory
effect of genistein and daidzein on protein synthesis in
osteoblastic MC3T3-E1 cells: Activation of aminoacyl-tRNA
synthetase. Mol Cell Biochem. 214:97–102. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu J, Wang XX, Takasaki M, Ohta A, Higuchi
M and Ishimi Y: Cooperative effects of exercise training and
genistein administration on bone mass in ovariectomized mice. J
Bone Miner Res. 16:1829–1836. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao LH, Wu MH and Xiang BR: Analysis of
Psoralea corylifolia L. fruits in different regions. Chem Pharm
Bull (Tokyo). 53:1054–1057. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen X, Kong L, Su X, Pan C, Ye M and Zou
H: Integration of ion-exchange chromatography fractionation with
reversed-phase liquid chromatography-atmospheric pressure chemical
ionization mass spectrometer and matrix-assisted laser
desorption/ionization time-of-flight mass spectrometry for
isolation and identification of compounds in Psoralea corylifolia.
J Chromatogr A. 1089:87–100. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang D, Yang G, Engelhardt H and Zhang H:
Micellar electrokinetic capillary chromatography of psoralen and
isopsoralen. Electrophoresis. 20:1895–1899. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xin D, Wang H, Yang J, Su YF, Fan GW, Wang
YF, Zhu Y and Gao XM: Phytoestrogens from Psoralea corylifolia
reveal estrogen receptor-subtype selectivity. Phytomedicine.
17:126–131. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ming LG, Cheng KM, Ge BF, Ma HP and Zai
YK: Effect of isopsoralen on the proliferation and differentiate of
osteoblasts in vitro. Zhong Yao Cai. 34:404–408. 2011.(In Chinese).
PubMed/NCBI
|
|
28
|
He Z, Feng L, Zhang X, Geng Y, Parodi DA,
Suarez-Quian C and Dym M: Expression of Col1a1, Col1a2 and
procollagen I in germ cells of immature and adult mouse testis.
Reproduction. 130:333–341. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lanyon L, Armstrong V, Ong D, Zaman G and
Price J: Is estrogen receptor alpha key to controlling bones'
resistance to fracture? J Endocrinol. 182:183–191. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
László A: Postmenopausal osteoporosis. Orv
Hetil. 145:3–13. 2004.(In Hungarian). PubMed/NCBI
|
|
31
|
Gallagher JC: Moderation of the daily dose
of HRT: Prevention of osteoporosis. Maturitas. 33 Suppl 1:S57–S63.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pardini D: Menopausal hormone therapy. Arq
Bras Endocrinol Metabol. 51:938–942. 2007.(In Portuguese).
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Prelevic GM, Kocjan T and Markou A:
Hormone replacement therapy in postmenopausal women. Minerva
Endocrinol. 30:27–36. 2005.PubMed/NCBI
|
|
34
|
Gonnelli S, Cepollaro C, Pondrelli C,
Martini S, Monaco R and Gennari C: The usefulness of bone turnover
in predicting the response to transdermal estrogen therapy in
postmenopausal osteoporosis. J Bone Miner Res. 12:624–631. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fitzpatrick LA: Estrogen therapy for
postmenopausal osteoporosis. Arq Bras Endocrinol Metabol.
50:705–719. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dören M and Samsioe G: Prevention of
postmenopausal osteoporosis with oestrogen replacement therapy and
associated compounds: Update on clinical trials since 1995. Hum
Reprod Update. 6:419–426. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pentti K, Honkanen R, Tuppurainen MT,
Sandini L, Kröger H and Saarikoski S: Hormone replacement therapy
and mortality in 52- to 70-year-old women: The kuopio osteoporosis
risk factor and prevention study. Eur J Endocrinol. 154:101–107.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nikander E, Metsä-Heikkilä M, Ylikorkala O
and Tiitinen A: Effects of phytoestrogens on bone turnover in
postmenopausal women with a history of breast cancer. J Clin
Endocrnol Metab. 89:1207–1212. 2004. View Article : Google Scholar
|
|
39
|
Deady J: Clinical monograph: Hormone
replacement therapy. J Manag Care Pharm. 10:33–47. 2004.PubMed/NCBI
|
|
40
|
Ashcroft GS, Dodsworth J, van Boxtel E,
Tarnuzzer RW, Horan MA, Schultz GS and Ferguson MW: Estrogen
accelerates cutaneous wound healing associated with an increase in
TGF-beta1 levels. Nat Med. 3:1209–1215. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bonewald LF and Mundy GR: Role of
transforming growth factor-beta in bone remodeling. Clin Orthop
Relat Res. 1–276. 1990.
|
|
42
|
Noda M and Camilliere JJ: In vivo
stimulation of bone formation by transforming growth factor-beta.
Endocrinology. 124:2991–2994. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Marie P: Growth factors and bone formation
in osteoporosis: Roles for IGF-I and TGF-beta. Rev Rhum Engl Ed.
64:44–53. 1997.PubMed/NCBI
|
|
44
|
Yamada Y, Miyauchi A, Goto J, Takagi Y,
Okuizumi H, Kanematsu M, Hase M, Takai H, Harada A and Ikeda K:
Association of a polymorphism of the transforming growth
factor-beta1 gene with genetic susceptibility to osteoporosis in
postmenopausal Japanese wome. J Bone Miner Res. 13:1569–1576. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Dennler S, Itoh S, Vivien D, ten Dijke P,
Huet S and Gauthier JM: Direct binding of Smad3 and Smad4 to
critical TGF beta-inducible elements in the promoter of human
plasminogen activator inhibitor-type 1 gene. EMBO J. 17:3091–3100.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Taxvig C, Elleby A, Sonne-Hansen K,
Bonefeld-Jørgensen EC, Vinggaard AM, Lykkesfeldt AE and Nellemann
C: Effects of nutrition relevant mixtures of phytoestrogens on
steroidogenesis, aromatase, estrogen, and androgen activity. Nutr
Cancer. 62:122–131. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Estai MA, Suhaimi F, Das S, Shuid AN,
Mohamed Z and Soelaiman IN: Expression of TGF-β1 in the blood
during fracture repair in an estrogen-deficient rat model. Clinics
(Sao Paulo). 66:2113–2119. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Limer JL and Speirs V: Phyto-oestrogens
and breast cancer chemoprevention. Breast Cancer Res. 6:119–127.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
49
|
Knight DC and Eden JA: A review of the
clinical effects of phytoestrogens. Obstet Gynecol. 87:897–904.
1996.PubMed/NCBI
|
|
50
|
Kavsak P, Rasmussen RK, Causing CG, Bonni
S, Zhu H, Thomsen GH and Wrana JL: Smad7 binds to Smurf2 to form an
E3 ubiquitin ligase that targets the TGF beta receptor for
degradation. Mol Cell. 6:1365–1375. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Souchelnytskyi S, Nakayama T, Nakao A,
Morén A, Heldin CH, Christian JL and ten Dijke P: Physical and
functional interaction of murine and Xenopus Smad7 with bone
morphogenetic protein receptors and transforming growth factor-beta
receptors. J Biol Chem. 273:25364–25370. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Peleg S, Uskokovic M, Ahene A, Vickery B
and Avnur Z: Cellular and molecular events associated with the
bone-protecting activity of the noncalcemic vitamin D analog
Ro-26-9228 in osteopenic rats. Endocrinology. 143:1625–1636. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Bord S, Beavan S, Ireland D, Horner A and
Compston JE: Mechanisms by which high-dose estrogen therapy
produces anabolic skeletal effects in postmenopausal women: Role of
locally produced growth factors. Bone. 29:216–222. 2001. View Article : Google Scholar : PubMed/NCBI
|
